Vitek 2 Systems bioART rule #5094 is predefined in response to a United States FDA limitation for bensylpenicillin and Streptococcus pneumoniae due to inadequate numbers of isolates at minimum inhibitory concentration (MIC) more than (or equal to) 8 ug/ml during impact AST-ST (antimicrobial susceptibility testing-Streptococca) cards. No AST-GP (gram positive) or AST-P cards are impacted. Note: bioART rule #5094 is enabled by default in the Vitek 2 7.01 Software.